Cargando…

The incidence of serious bleeding events in a global, single-arm, open-label trial of Drotrecogin alfa (activated) in adult patients with severe sepsis (ENHANCE): comparisons with PROWESS

Detalles Bibliográficos
Autores principales: Beale, R, Vincent, J, Doig, C, Dhainaut, J, Sundin, D, Wright, T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2004
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4099703/
http://dx.doi.org/10.1186/cc2583
_version_ 1782326527276351488
author Beale, R
Vincent, J
Doig, C
Dhainaut, J
Sundin, D
Wright, T
author_facet Beale, R
Vincent, J
Doig, C
Dhainaut, J
Sundin, D
Wright, T
author_sort Beale, R
collection PubMed
description
format Online
Article
Text
id pubmed-4099703
institution National Center for Biotechnology Information
language English
publishDate 2004
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40997032014-09-23 The incidence of serious bleeding events in a global, single-arm, open-label trial of Drotrecogin alfa (activated) in adult patients with severe sepsis (ENHANCE): comparisons with PROWESS Beale, R Vincent, J Doig, C Dhainaut, J Sundin, D Wright, T Crit Care Poster Presentation BioMed Central 2004 2004-03-15 /pmc/articles/PMC4099703/ http://dx.doi.org/10.1186/cc2583 Text en
spellingShingle Poster Presentation
Beale, R
Vincent, J
Doig, C
Dhainaut, J
Sundin, D
Wright, T
The incidence of serious bleeding events in a global, single-arm, open-label trial of Drotrecogin alfa (activated) in adult patients with severe sepsis (ENHANCE): comparisons with PROWESS
title The incidence of serious bleeding events in a global, single-arm, open-label trial of Drotrecogin alfa (activated) in adult patients with severe sepsis (ENHANCE): comparisons with PROWESS
title_full The incidence of serious bleeding events in a global, single-arm, open-label trial of Drotrecogin alfa (activated) in adult patients with severe sepsis (ENHANCE): comparisons with PROWESS
title_fullStr The incidence of serious bleeding events in a global, single-arm, open-label trial of Drotrecogin alfa (activated) in adult patients with severe sepsis (ENHANCE): comparisons with PROWESS
title_full_unstemmed The incidence of serious bleeding events in a global, single-arm, open-label trial of Drotrecogin alfa (activated) in adult patients with severe sepsis (ENHANCE): comparisons with PROWESS
title_short The incidence of serious bleeding events in a global, single-arm, open-label trial of Drotrecogin alfa (activated) in adult patients with severe sepsis (ENHANCE): comparisons with PROWESS
title_sort incidence of serious bleeding events in a global, single-arm, open-label trial of drotrecogin alfa (activated) in adult patients with severe sepsis (enhance): comparisons with prowess
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4099703/
http://dx.doi.org/10.1186/cc2583
work_keys_str_mv AT bealer theincidenceofseriousbleedingeventsinaglobalsinglearmopenlabeltrialofdrotrecoginalfaactivatedinadultpatientswithseveresepsisenhancecomparisonswithprowess
AT vincentj theincidenceofseriousbleedingeventsinaglobalsinglearmopenlabeltrialofdrotrecoginalfaactivatedinadultpatientswithseveresepsisenhancecomparisonswithprowess
AT doigc theincidenceofseriousbleedingeventsinaglobalsinglearmopenlabeltrialofdrotrecoginalfaactivatedinadultpatientswithseveresepsisenhancecomparisonswithprowess
AT dhainautj theincidenceofseriousbleedingeventsinaglobalsinglearmopenlabeltrialofdrotrecoginalfaactivatedinadultpatientswithseveresepsisenhancecomparisonswithprowess
AT sundind theincidenceofseriousbleedingeventsinaglobalsinglearmopenlabeltrialofdrotrecoginalfaactivatedinadultpatientswithseveresepsisenhancecomparisonswithprowess
AT wrightt theincidenceofseriousbleedingeventsinaglobalsinglearmopenlabeltrialofdrotrecoginalfaactivatedinadultpatientswithseveresepsisenhancecomparisonswithprowess
AT bealer incidenceofseriousbleedingeventsinaglobalsinglearmopenlabeltrialofdrotrecoginalfaactivatedinadultpatientswithseveresepsisenhancecomparisonswithprowess
AT vincentj incidenceofseriousbleedingeventsinaglobalsinglearmopenlabeltrialofdrotrecoginalfaactivatedinadultpatientswithseveresepsisenhancecomparisonswithprowess
AT doigc incidenceofseriousbleedingeventsinaglobalsinglearmopenlabeltrialofdrotrecoginalfaactivatedinadultpatientswithseveresepsisenhancecomparisonswithprowess
AT dhainautj incidenceofseriousbleedingeventsinaglobalsinglearmopenlabeltrialofdrotrecoginalfaactivatedinadultpatientswithseveresepsisenhancecomparisonswithprowess
AT sundind incidenceofseriousbleedingeventsinaglobalsinglearmopenlabeltrialofdrotrecoginalfaactivatedinadultpatientswithseveresepsisenhancecomparisonswithprowess
AT wrightt incidenceofseriousbleedingeventsinaglobalsinglearmopenlabeltrialofdrotrecoginalfaactivatedinadultpatientswithseveresepsisenhancecomparisonswithprowess